Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

ROMIPLOSTIM

FDA · BLA · 2025-02-21

AgencyFDA
Submission typeBLA
Action date2025-02-21
BrandNPLATE
SponsorAMGEN
RouteSUBCUTANEOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:21.678Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:ROMIPLOSTIM:2025-02-21

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

ROMIPLOSTIM — approval | AEaH